These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 37604314

  • 1. Pharmacokinetics/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection.
    Casale TB, Ellis AK, Nowak-Wegrzyn A, Kaliner M, Lowenthal R, Tanimoto S.
    J Allergy Clin Immunol; 2023 Dec; 152(6):1587-1596. PubMed ID: 37604314
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: An integrated analysis.
    Tanimoto S, Kaliner M, Lockey RF, Ebisawa M, Koplowitz LP, Koplowitz B, Lowenthal R.
    Ann Allergy Asthma Immunol; 2023 Apr; 130(4):508-514.e1. PubMed ID: 36334720
    [Abstract] [Full Text] [Related]

  • 3. Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions.
    Ellis AK, Casale TB, Kaliner M, Oppenheimer J, Spergel JM, Fleischer DM, Bernstein D, Camargo CA, Lowenthal R, Tanimoto S.
    Pharmaceutics; 2024 Jun 14; 16(6):. PubMed ID: 38931932
    [Abstract] [Full Text] [Related]

  • 4. The impact of anaphylaxis on the absorption of intranasal epinephrine in anaesthetized non-naive beagle dogs.
    Sparapani S, Authier S, Lowenthal R, Tanimoto S.
    J Allergy Clin Immunol Glob; 2023 Nov 14; 2(4):100165. PubMed ID: 38024850
    [Abstract] [Full Text] [Related]

  • 5. Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances.
    Worm M, Nguyen D, Rackley R, Muraro A, Du Toit G, Lawrence T, Li H, Brumbaugh K, Wickman M.
    Clin Transl Allergy; 2020 Nov 14; 10():21. PubMed ID: 32528643
    [Abstract] [Full Text] [Related]

  • 6. Usability and preference of epinephrine auto-injectors: Auvi-Q and EpiPen Jr.
    Kessler C, Edwards E, Dissinger E, Sye S, Visich T, Grant E.
    Ann Allergy Asthma Immunol; 2019 Sep 14; 123(3):256-262. PubMed ID: 31228629
    [Abstract] [Full Text] [Related]

  • 7. A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector.
    Dworaczyk DA, Hunt AL, Di Spirito M, Lor M, Dretchen KL, Lamson MJ, Pollock J, Ward T.
    J Allergy Clin Immunol Glob; 2024 May 14; 3(2):100200. PubMed ID: 38328805
    [Abstract] [Full Text] [Related]

  • 8. EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.
    Simons FE, Gu X, Silver NA, Simons KJ.
    J Allergy Clin Immunol; 2002 Jan 14; 109(1):171-5. PubMed ID: 11799385
    [Abstract] [Full Text] [Related]

  • 9. Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis.
    Tal Y, Ribak Y, Rubin L, Talmon A, Shamriz O, Hershko AY, Blotnick S, Bouhajib M, Krayz GT, Abrutzky C, Megiddo D, Lapidot T, Caraco Y.
    J Allergy Clin Immunol Pract; 2023 Oct 14; 11(10):3047-3054. PubMed ID: 37394178
    [Abstract] [Full Text] [Related]

  • 10. Rapid increases in epinephrine concentration following presumed intra-blood vessel administration via epinephrine autoinjector.
    Ebisawa M, Kaliner MA, Lowenthal R, Tanimoto S.
    J Allergy Clin Immunol Glob; 2023 Aug 14; 2(3):100118. PubMed ID: 37779532
    [Abstract] [Full Text] [Related]

  • 11. Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study.
    Patel N, Isaacs E, Duca B, Nagaratnam N, Donovan J, Fontanella S, Turner PJ.
    Allergy; 2023 Jul 14; 78(7):1997-2006. PubMed ID: 36794963
    [Abstract] [Full Text] [Related]

  • 12. An epinephrine nasal spray (neffy) for anaphylaxis.
    Med Lett Drugs Ther; 2024 Oct 14; 66(1713):163-164. PubMed ID: 39382429
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epinephrine in the Management of Anaphylaxis.
    Brown JC, Simons E, Rudders SA.
    J Allergy Clin Immunol Pract; 2020 Apr 14; 8(4):1186-1195. PubMed ID: 32276687
    [Abstract] [Full Text] [Related]

  • 15. Detecting epinephrine auto-injector shortages in Finland 2016-2022: Log-data analysis of online information seeking.
    Mukka M, Pesälä S, Mustonen P, Kaila M, Helve O.
    PLoS One; 2024 Apr 14; 19(4):e0299092. PubMed ID: 38603709
    [Abstract] [Full Text] [Related]

  • 16. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
    Rawas-Qalaji MM, Simons FE, Simons KJ.
    J Allergy Clin Immunol; 2006 Feb 14; 117(2):398-403. PubMed ID: 16461140
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
    Moss J, Jani Y, Edwards B, Tomlin S, Rashed AN.
    Br J Clin Pharmacol; 2021 Mar 14; 87(3):816-824. PubMed ID: 32559814
    [Abstract] [Full Text] [Related]

  • 18. Innovations in the treatment of anaphylaxis: A review of recent data.
    Lieberman JA, Oppenheimer J, Hernandez-Trujillo VP, Blaiss MS.
    Ann Allergy Asthma Immunol; 2023 Aug 14; 131(2):185-193.e10. PubMed ID: 37279803
    [Abstract] [Full Text] [Related]

  • 19. Economic evaluation of epinephrine auto-injectors for peanut allergy.
    Shaker M, Bean K, Verdi M.
    Ann Allergy Asthma Immunol; 2017 Aug 14; 119(2):160-163. PubMed ID: 28634019
    [Abstract] [Full Text] [Related]

  • 20. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen).
    Gold MS, Sainsbury R.
    J Allergy Clin Immunol; 2000 Jul 14; 106(1 Pt 1):171-6. PubMed ID: 10887321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.